Vaxart Inc

NASDAQ:VXRT   9:35:32 AM EDT
0.44
-0.02 (-4.31%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)100.45M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.03 Million
Adjusted EPS-$0.09
See more estimates
10-Day MA$0.50
50-Day MA$0.46
200-Day MA$0.61
See more pivots

Vaxart Inc Stock, NASDAQ:VXRT

170 Harbor Way, Suite 300, South San Francisco, California 94080
United States of America
Phone: +1.650.550.3500
Number of Employees: 125
http://www.vaxart.com

Description

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded in March 2004 and is headquartered in South San Francisco, CA.